Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Improving pain relief for patients with advanced cancers
A trans-national clinical trial, involving Peter Mac patients, has found stereotactic ablative body radiation therapy…
Discovery gives hope of detecting and preventing prostate cancer spread
New research by QIMR Berghofer Medical Research Institute and The University of Queensland has revealed…
Naked mole rats provide clues to curing cancer and dementia
Scientists say naked mole rats – a rodent native to West Africa – may hold…
We don’t need to change how we subsidise ‘breakthrough’ cancer treatments
Richard De Abreu Lourenco, University of Technology Sydney; Marion Haas, University of Technology Sydney, and Rosalie Viney, University of Technology…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.